[Experience with montelukast, a leukotriene receptor antagonist, in pediatric patients with asthma].

AudienciaPúblico en generales_ES
CoberturaMéxicoes_ES
Fecha de ingreso2026-09-15T00:31:30Z
Fecha de publicación2002-01-30
ResumenBACKGROUND: Montelukast is a specific antagonist of leukotrienes' receptors and constitutes a therapeutic option in controlling asthma. OBJECTIVES: To evaluate efficacy of montelukast in patients with persistent light asthma, persistent moderate asthma and exercise-induced asthma; to try to reduce or to eliminate doses of inhaled steroid; to reduce the use of short-action beta agonists and to assess its tolerability in pediatric patients. MATERIAL AND METHOD: 40 patients were studied, 17 female, with an age range from 4 to 11 years and a mean of 7 years. Stratification was made by GINA-established parameters. RESULTS: Steroid dose could be reduced in 88%, with definitive suspension in 66% of patients. Moreover, an improvement in reducing asthma stratification and the use of rescue drugs were registered. 62% of patients with exercise-induced asthma improved and there was a good tolerance with the same side effects.es_ES
URIhttps://riuat.uat.edu.mx/handle/123456789/3178
Idiomaeses_ES
EditorialNational Institutes of Healthes_ES
RelaciónPubMedes_ES
URL relacionadohttps://pubmed.ncbi.nlm.nih.gov/11759254es_ES
DerechosAcceso restringido / Suscripción (Metadatos de producción científica)es_ES
Licenciahttp://purl.org/coar/access_right/c_16eces_ES
FuentePubMed
Palabra claveMontelukastes_ES
Palabra claveMedicinees_ES
Palabra claveAsthmaes_ES
Palabra claveTolerabilityes_ES
Palabra claveLeukotriene receptores_ES
Palabra claveAntagonistes_ES
Palabra claveLeukotrienees_ES
Palabra claveB2 receptores_ES
Palabra claveInternal medicinees_ES
Palabra claveAnesthesiaes_ES
Palabra clavePharmacologyes_ES
Palabra claveAdverse effectes_ES
ClasificaciónAsthma and respiratory diseaseses_ES
Título[Experience with montelukast, a leukotriene receptor antagonist, in pediatric patients with asthma].es_ES
TipoArtículoes_ES
ArbitradoHa sido Arbitradoes_ES
AutorM, Vega López
AutorR, Jiménez Ferral
AutorM, Vega Lópezes_ES
AutorR, Jiménez Ferrales_ES
InstituciónUniversidad Autónoma de Tamaulipas
InstituciónUniversidad Autónoma de Tamaulipases_ES
Número5es_ES
Rango de páginas133-6es_ES
URL relacionadahttps://pubmed.ncbi.nlm.nih.gov/11759254
Tipo de artículoIndexado
Tipo de artículoIndexadoes_ES
Volumen48es_ES

Files